The Latest Headlines at Ticker Report
Elicio Therapeutics, Inc. (NASDAQ:ELTX) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Elicio Therapeutics, Inc. (NASDAQ:ELTX – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat.com reports. One research analyst... More of this article »
Beyond Meat, Inc. (NASDAQ:BYND) Given Average Rating of “Strong Sell” by Brokerages
Shares of Beyond Meat, Inc. (NASDAQ:BYND – Get Free Report) have been assigned an average rating of “Strong Sell” from the nine brokerages that are presently covering the firm, MarketBeat.com reports. Six equities... More of this article »
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) have received a consensus rating of “Buy” from the six analysts that are covering the stock, Marketbeat reports. One equities research analyst... More of this article »
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Recommendation of “Hold” by Analysts
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) has earned an average recommendation of “Hold” from the six research firms that are presently covering the stock, MarketBeat reports. One equities research analyst... More of this article »
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Average Rating of “Moderate Buy” from Brokerages
Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ten brokerages that are presently covering the stock, MarketBeat reports. One research analyst has... More of this article »
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Given Average Rating of “Hold” by Brokerages
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have received an average rating of “Hold” from the five research firms that are covering the company, MarketBeat Ratings reports. One equities... More of this article »
Optimum Communications, Inc. (NYSE:OPTU) Receives Consensus Recommendation of “Reduce” from Analysts
Optimum Communications, Inc. (NYSE:OPTU – Get Free Report) has received an average recommendation of “Reduce” from the nine research firms that are currently covering the firm, MarketBeat Ratings reports. Three equities... More of this article »
Radian Group Inc. (NYSE:RDN) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Radian Group Inc. (NYSE:RDN – Get Free Report) has received an average rating of “Moderate Buy” from the eight research firms that are currently covering the stock, Marketbeat.com reports. Three equities research... More of this article »
Astronics (NASDAQ:ATRO) vs. Teledyne Technologies (NYSE:TDY) Financial Analysis
Teledyne Technologies (NYSE:TDY – Get Free Report) and Astronics (NASDAQ:ATRO – Get Free Report) are both aerospace companies, but which is the better stock? We will contrast the two businesses based on the strength of... More of this article »
Perrigo Company plc (NYSE:PRGO) Given Average Recommendation of “Hold” by Analysts
Shares of Perrigo Company plc (NYSE:PRGO – Get Free Report) have earned an average rating of “Hold” from the six analysts that are presently covering the firm, MarketBeat.com reports. One equities research analyst... More of this article »
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Recommendation of “Hold” from Brokerages
Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) has been assigned an average recommendation of “Hold” from the four ratings firms that are presently covering the company, Marketbeat.com reports. One... More of this article »
Cavco Industries, Inc. (NASDAQ:CVCO) Given Consensus Rating of “Moderate Buy” by Brokerages
Cavco Industries, Inc. (NASDAQ:CVCO – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are presently covering the stock, MarketBeat.com reports. Three equities research... More of this article »
Cardiff Oncology, Inc. (NASDAQ:CRDF) Receives Consensus Rating of “Hold” from Brokerages
Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) has been given a consensus rating of “Hold” by the seven research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated... More of this article »